Welcome
Support Centre
21 November 2008 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Treatment of bowel dysfunction in stroke patients: a randomised controlled trial
ISRCTN ISRCTN87167979
ClinicalTrials.gov identifier
Public title Treatment of bowel dysfunction in stroke patients: a randomised controlled trial
Scientific title
Acronym N/A
Serial number at source AP0763
Study hypothesis Not provided at time of registration
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Bowel dysfunction
Participants - inclusion criteria Patients with symptoms of faecal incontinence, constipation, and/or rectal outlet delay who are within 2 years of acute stroke
Participants - exclusion criteria Not provided at time of registration
Anticipated start date 01/01/2003
Anticipated end date 01/01/2004
Status of trial Completed
Patient information material
Target number of participants Not provided at time of registration
Interventions Stroke patients within 2 years of their initial acute Cerebrovascular Accident (CVA) will be screened by a 9-item bowel symptom questionnaire and cognitive assessment. Eligible patients will be randomised to intervention or control groups.

1. The intervention group will undergo a single clinical assessment including a symptom history, rectal examination, and where relevant, an abdominal radiograph leading to a treatment programme consisting of appropriate bowel medications, sphincter exercises where relevant and education with the use of a self-care booklet on all issues relevant to bowel problems in stroke.

2. The control group will receive usual care from their hospital or General Practitioner.
Primary outcome measure(s) Not provided at time of registration
Secondary outcome measure(s) Not provided at time of registration
Sources of funding Action Medical Research (UK)
Trial website
Publications Results in http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=15486330
Contact name Dr  Danielle  Harari
  Address Elderly Care Unit
9th Floor North Wing
St.Thomas' Hospital
Lambeth Palace Road
  City/town London
  Zip/Postcode SE1 7EH
  Country United Kingdom
  Tel +44 (0)20 7922 8039
  Fax +44 (0)20 7928 2339
  Email danielle.harari@kcl.ac.uk
Sponsor Action Medical Research (UK)
  Address Vincent House
  City/town Horsham West Sussex
  Zip/Postcode RH12 2DP
  Country United Kingdom
Date applied 01/03/2001
Last edited 07/09/2007
Date ISRCTN assigned 01/03/2001
Submit your trial protocol Top studies in medical research Submit to Trials journal
© ISRCTN


BioMed Central